0001209191-16-090183.txt : 20160106
0001209191-16-090183.hdr.sgml : 20160106
20160106202726
ACCESSION NUMBER: 0001209191-16-090183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160104
FILED AS OF DATE: 20160106
DATE AS OF CHANGE: 20160106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halstead Michael
CENTRAL INDEX KEY: 0001521548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 161328585
MAIL ADDRESS:
STREET 1: C/O WARNER CHILCOTT CORPORATION
STREET 2: 100 ENTERPRISE DRIVE
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-04
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001521548
Halstead Michael
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
0
1
0
0
SVP and General Counsel
Stock Option (right to buy)
53.63
2016-01-04
4
A
0
39307
0.00
A
2017-01-04
2026-01-04
Common Stock
39307
39307
D
Restricted Stock Units
2016-01-04
4
A
0
9323
0.00
A
2017-01-04
Common Stock
9323
9323
D
The Stock Option vests as to one third of the shares on January 4, 2017, one third of the shares on January 4, 2018 and one third of the shares on January 4, 2019.
Each Restricted Stock Unit represents a contingent right to receive one share of common stock, par value $0.0001 per share, of Intra-Cellular Therapies, Inc.
The Restricted Stock Units vest as to one third of the shares on January 4, 2017, one third of the shares on January 4, 2018 and one third of the shares on January 4, 2019, subject to the reporting person's continuous service with Intra-Cellular Therapies, Inc. through each such vesting date. Vested shares will be delivered to the reporting person within three days of each such vesting date.
/s/ Lawrence J. Hineline, Attorney-in-fact
2016-01-06